'); //--> Back to Boston.com homepage Arts | Entertainment Boston Globe Online Cars.com BostonWorks Real Estate Boston.com Sports digitalMass Travel
Home
Help

Top Ten
1. Charles River Labs
2. TJX
3. Perini
4. Investors Fin. Svcs.
5. Gillette
6. Staples
7. OneSource
8. Reebok
9. Bright Horizons
10. State Street
2002 Globe 100

Year's Best
Company of year
Highest market value
Highest sales
Comeback of the year
Biggest stock gain
Fastest growth

Features
Overall performance
Bulls and Bears
  Bulls
  1. Clean Harbors
  2. Hologic
  3. NMT Medical
  4. DeWolfe
  5. Indevus Pharm.
  Bears
  1. Sonus Networks
  2. Art Tech. Group
  3. Praecis Pharm.
  4. American Tower
  5. Dusa Pharmaceutical
Banking
Market value
Sales
Biotech
Medical devices
Growth
  1. Cytyc
  2. Polymedica Corp.
  3. Perini
  4. Tweeter
  5. Boston Private Fin.
Telecom
Employment
Technology
IPOs
Company profiles
Globe 100 notes

Get the chart
The 2002 Globe 100
All the charts


Sections Boston Globe Online: Page One Nation | World Metro | Region Business Sports Living | Arts Editorials


Search the Globe:

Today
Yesterday

The Boston Globe OnlineBoston.com The Best in Massachusetts Business
Sponsored by

Most highly leveraged companies

Ranked by highest long-term debt to shareholders' equity.

Rank Company Long-term
debt ($ millions)
Common equity
($ millions)
Debt to
equity ratio
1 Nextera Enterprises Inc. 48.25 2.56 18.88
2 Akamai Technologies Inc. 300.11 17.23 17.41
3 HPSC Inc. 270.01 39.66 6.81
4 Abington Bancorp 205.66 39.15 5.25
5 Bostonfed Bancorp 481.00 93.39 5.15
6 Lionbridge Technologies Inc. 17.32 3.45 5.02
7 Applied Extrusion Technologies Inc. 279.57 74.69 3.74
8 CCBT Financial Cos. 389.31 115.32 3.38
9 Independent Bank Corp. 396.23 133.26 2.97
10 Sonesta International Hotels (class A) 74.12 27.22 2.72
NOTE: Company must have had 2001 sales of at least $25 million and have been a public company since Dec. 31, 2000. Data compiled by Compustat.


© Copyright 2002 Boston Globe Electronic Publishing Inc.
| Advertise | Contact us | Privacy policy |